Zum Inhalt springen
+49 (0) 3302 20 94 49 - 0Neuendorfstraße 23 b/d 16761 Hennigsdorf (Germany)info@pentracor.de
Facebook page opens in new windowTwitter page opens in new windowYouTube page opens in new window
Pentracor
PentracorPentracor
  • Home
  • Therapy
    • CRP apheresis
    • CRP adsorber
    • Range of Applications
    • Applying Centers
    • Specialist Information
    • Publications
  • Services
  • About us
    • About us
    • Career
    • Medical Advisory Board
    • Partners
    • Investors
    • Funding projects
  • Investor Relations
    • Investor Relations
    • Bond
    • Financial Publications
    • Financial Releases
    • Questions & Answers
  • News
    • News
    • Press Releases
    • Published Papers
    • Awards
    • Webinars
    • Events
    • Other
  • Contact
Book a visit
  • Home
  • Therapy
    • CRP apheresis
    • CRP adsorber
    • Range of Applications
    • Applying Centers
    • Specialist Information
    • Publications
  • Services
  • About us
    • About us
    • Career
    • Medical Advisory Board
    • Partners
    • Investors
    • Funding projects
  • Investor Relations
    • Investor Relations
    • Bond
    • Financial Publications
    • Financial Releases
    • Questions & Answers
  • News
    • News
    • Press Releases
    • Published Papers
    • Awards
    • Webinars
    • Events
    • Other
  • Contact

Further publication on CAMI1 study in Nephro-News

Sie befinden sich hier:
  1. Start
  2. News
  3. Weitere Veröffentlichung zur CAMI1-Studie in…
01.06.2019

The first data acquired within the CAMI1 study were again described and published within the magazine NephroNews.

 

Company name
Pentracor GmbH
  • Phone number:
    +49 (0) 3302 20 94 49 - 0
  • Address:
    Neuendorfstraße 23 b / d
    16761 Hennigsdorf (Germany)
  • E-Mail
    info@pentracor.de
  • Home
  • Therapy
  • Services
  • About us
  • Investor Relations
  • News
  • Contact
  • Privacy policy
  • Imprint
Go to Top
en_GB
en_GB de_DE